Voloridge Investment Management
CDLX icon

Voloridge Investment Management’s Cardlytics CDLX Stock Holding History

Voloridge Investment Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,031
Closed -$522K – 1382
2022
Q4 		$522K Sell
9,031
-31,220
-78% -$1.93M ﹤0.01% 1263
2022
Q3 		$3.78M Buy
40,251
+17,100
+74% +$2.43M 0.02% 754
2022
Q2 		$5.17M Buy
23,151
+11,122
+92% +$3.72M 0.03% 662
2022
Q1 		$6.61M Sell
12,029
-2,794
-19% -$1.69M 0.04% 545
2021
Q4 		$9.8M Buy
14,823
+6,181
+72% +$4.73M 0.05% 477
2021
Q3 		$7.25M Sell
8,642
-2,102
-20% -$2.13M 0.05% 542
2021
Q2 		$13.6M Sell
10,744
-5,290
-33% -$5.97M 0.09% 292
2021
Q1 		$17.6M Buy
16,034
+7,473
+87% +$9.87M 0.13% 205
2020
Q4 		$12.2M Buy
+8,561
New +$9.13M 0.1% 233
2020
Q3 		– Sell
-1,347
Closed -$943K – 1267
2020
Q2 		$943K Sell
1,347
-8,255
-86% -$4.77M 0.01% 870
2020
Q1 		$3.36M Buy
+9,602
New +$6.8M 0.1% 228

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GEH
General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

Voloridge Investment Management's CDLX Position: Q1 2023 in Review

Voloridge Investment Management sold out of Cardlytics (CDLX) in Q1 2023, closing a stake of 9,031 shares — an estimated $522K sold.

Voloridge Investment Management first reported a position in CDLX in Q1 2020 and held it in 11 quarters. The position peaked at $17.6M in Q1 2021. 103 funds tracked by Wall St. Rank hold CDLX as of Q1 2023.

  • Voloridge Investment Management reported no remaining Cardlytics position as of Q1 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 9,031 Cardlytics shares in Q1 2023, an estimated $522K.
  • Voloridge Investment Management first reported a position in Cardlytics in Q1 2020 and held it in 11 quarters.
  • Voloridge Investment Management's Cardlytics position peaked at $17.6M in Q1 2021.
  • 103 funds tracked by Wall St. Rank held Cardlytics as of Q1 2023.

Based on Voloridge Investment Management's 13F filing for Q1 2023, filed 15 May 2023.